Literature DB >> 31289848

Distribution of colorectal cancer in young African Americans: implications for the choice of screening test.

Tarek H Hassab1,2, Lior Segev3, Matthew F Kalady1,4, James M Church5,6.   

Abstract

BACKGROUND: We recently reported on a left-sided predominance of colorectal cancers in the young (under age 50). Given the predilection of young African Americans for the disease, we wondered if there may be a difference in the biology of colorectal carcinogenesis between this group and Caucasians.
OBJECTIVE: Compare the distribution of colorectal cancer in African American patients and Caucasians under age 50, and describe implications for screening in these groups. PATIENTS: Colorectal cancer patients diagnosed under the age of 50 between the years 2000 and 2016. All races other than African American and Caucasian and all patients with hereditary colon cancer or inflammatory bowel disease were excluded. OUTCOME MEASURES: race, age at diagnosis (5 subgroups: < 20, 20-29, 30-39, 40-44, and 45-49 years) and cancer location; right (cecum, ascending colon, hepatic flexure, transverse colon, splenic flexure), left (descending colon and sigmoid colon), or rectal.
RESULTS: 759 patients were included; 695 (91.6%) were Caucasian and 64 (8.4%) were African American. Most cases were diagnosed between ages 40 and 49 (African American = 75%, Caucasian = 69.5%). Rectal cancer was most common in both races, although significantly more common in Caucasian than in African American patients (64.2% vs 39.1%). Right colon cancer was more commonly found in African Americans (37.5%) compared with Caucasians (18%) (p = 0.0002). The ratio of rectal to right-sided colon cancer in African Americans was 1:1 compared with 3.6:1 in Caucasians. LIMITATIONS: Relatively low number of African American patients
CONCLUSION: The high rate of right-sided cancer in young African American patients means that they should be screened with colonoscopy. The increased incidence of right-sided cancers may represent a different biology of carcinogenesis in African Americans and deserves further study.

Entities:  

Keywords:  Cancer location; Colorectal cancer; Race

Mesh:

Year:  2019        PMID: 31289848     DOI: 10.1007/s00384-019-03338-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

1.  Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.

Authors:  Andrew M D Wolf; Elizabeth T H Fontham; Timothy R Church; Christopher R Flowers; Carmen E Guerra; Samuel J LaMonte; Ruth Etzioni; Matthew T McKenna; Kevin C Oeffinger; Ya-Chen Tina Shih; Louise C Walter; Kimberly S Andrews; Otis W Brawley; Durado Brooks; Stacey A Fedewa; Deana Manassaram-Baptiste; Rebecca L Siegel; Richard C Wender; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2018-05-30       Impact factor: 508.702

2.  DNA methylome profiling identifies novel methylated genes in African American patients with colorectal neoplasia.

Authors:  Hassan Ashktorab; M Daremipouran; Ajay Goel; Sudhir Varma; R Leavitt; Xueguang Sun; Hassan Brim
Journal:  Epigenetics       Date:  2014-01-17       Impact factor: 4.528

3.  The relation of age, race, and gender to the subsite location of colorectal carcinoma.

Authors:  R L Nelson; T Dollear; S Freels; V Persky
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

4.  Carcinoma in situ of the colorectum: SEER trends by race, gender, and total colorectal cancer.

Authors:  R L Nelson; V Persky; M Turyk
Journal:  J Surg Oncol       Date:  1999-06       Impact factor: 3.454

5.  The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity.

Authors:  Paul J H L Peeters; Marloes T Bazelier; Hubert G M Leufkens; Frank de Vries; Marie L De Bruin
Journal:  Diabetes Care       Date:  2014-12-31       Impact factor: 19.112

6.  Influence of demographics on colorectal cancer.

Authors:  Gamal Mostafa; Brent D Matthews; H James Norton; Kent W Kercher; Ronald F Sing; B Todd Heniford
Journal:  Am Surg       Date:  2004-03       Impact factor: 0.688

7.  American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected].

Authors:  Douglas K Rex; David A Johnson; Joseph C Anderson; Phillip S Schoenfeld; Carol A Burke; John M Inadomi
Journal:  Am J Gastroenterol       Date:  2009-02-24       Impact factor: 10.864

8.  Multitarget stool DNA testing for colorectal-cancer screening.

Authors:  Thomas F Imperiale; David F Ransohoff; Steven H Itzkowitz; Theodore R Levin; Philip Lavin; Graham P Lidgard; David A Ahlquist; Barry M Berger
Journal:  N Engl J Med       Date:  2014-03-19       Impact factor: 91.245

9.  Oxidative stress induces nuclear-to-cytosol shift of hMSH3, a potential mechanism for EMAST in colorectal cancer cells.

Authors:  Stephanie S Tseng-Rogenski; Heekyung Chung; Maike B Wilk; Shuai Zhang; Moriya Iwaizumi; John M Carethers
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

10.  Reduced Representation Bisulfite Sequencing Determination of Distinctive DNA Hypermethylated Genes in the Progression to Colon Cancer in African Americans.

Authors:  Hassan Ashktorab; Afnan Shakoori; Shatha Zarnogi; Xueguang Sun; Sudhir Varma; Edward Lee; Babak Shokrani; Adeyinka O Laiyemo; Kareem Washington; Hassan Brim
Journal:  Gastroenterol Res Pract       Date:  2016-09-01       Impact factor: 2.260

View more
  1 in total

1.  Correlation of Serum CA242, CA724, and TPA Levels with Clinicopathological Features and Prognosis in Patients with Inflammatory Bowel Disease Complicated with Rectal Cancer.

Authors:  Hongliang Liang; Xi Yang
Journal:  J Oncol       Date:  2022-09-19       Impact factor: 4.501

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.